Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

QURE

uniQure NV

May 29 • 04:00PM ET

28.53

+3.68 14.81 %

Healthcare • Biotechnology • Netherlands • Small • NASD

Peers: BEAM NTLA CRSP EDIT VIR BMRN RYTM IONS ALNY INCY

| Held by: XBI VXF IBB SCHA JGRO KOMP LABU ITOT GNOM SCHB

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.51	Insider Own	9.52%	Shs Outstand	63.03M	Perf Week	15.23%
Market Cap	1.78B	Forward P/E	-	EPS next Y	-3.05	Insider Trans	-2.99%	Shs Float	56.58M	Perf Month	70.53%
Enterprise Value	1.74B	PEG	-	EPS next Q	-0.84	Inst Own	88.50%	Short Float	18.20%	Perf Quarter	82.53%
Income	-208.87M	P/S	98.62	EPS this Y	-1.41%	Inst Trans	-6.23%	Short Ratio	3.59	Perf Half Y	2.04%
Sales	18.09M	P/B	12.04	EPS next Y	13.22%	ROA	-30.18%	Short Interest	10.30M	Perf YTD	19.22%
Book/sh	2.37	P/C	3.04	EPS next 5Y	10.70%	ROE	-228.24%	52W High	71.50 -60.10%	Perf Year	91.48%
Cash/sh	9.38	P/FCF	-	EPS past 3/5Y	-8.45% -4.24%	ROIC	-30.18%	52W Low	8.73 226.80%	Perf 3Y	46.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-46.73% -15.57%	Gross Margin	17.67%	Volatility	5.27% 8.82%	Perf 5Y	-17.85%
Dividend TTM	-	EV/Sales	96.36	EPS Y/Y TTM	19.99%	Oper. Margin	-1082.08%	ATR (14)	1.95	Perf 10Y	137.95%
Dividend Ex-Date	-	Quick Ratio	10.40	Sales Y/Y TTM	-10.44%	Profit Margin	-1154.42%	RSI (14)	68.51	Recom	1.57
Dividend Gr. 3/5Y	- -	Current Ratio	10.40	EPS Q/Q	-3.85%	SMA20	13.40%	Beta	0.92	Target Price	38.33
Payout	-	Debt/Eq	3.65	Sales Q/Q	127.31%	SMA50	41.56%	Rel Volume	1.24	Prev Close	24.85
Employees	221	LT Debt/Eq	3.63	Earnings	May 05 BMO	SMA200	7.58%	Avg Volume	2.86M	Price	28.53
IPO	Feb 05, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.71% -31.56%	Trades		Volume	3,550,951	Change	14.81%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)